KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Other Non-Current Assets (2017 - 2025)

Historic Other Non-Current Assets for Aquestive Therapeutics (AQST) over the last 9 years, with Q3 2025 value amounting to $3.2 million.

  • Aquestive Therapeutics' Other Non-Current Assets fell 2437.35% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year decrease of 2437.35%. This contributed to the annual value of $4.2 million for FY2024, which is 2234.28% down from last year.
  • Latest data reveals that Aquestive Therapeutics reported Other Non-Current Assets of $3.2 million as of Q3 2025, which was down 2437.35% from $3.2 million recorded in Q2 2025.
  • Aquestive Therapeutics' Other Non-Current Assets' 5-year high stood at $7.8 million during Q1 2021, with a 5-year trough of $3.2 million in Q3 2025.
  • Over the past 5 years, Aquestive Therapeutics' median Other Non-Current Assets value was $5.5 million (recorded in 2023), while the average stood at $5.5 million.
  • Per our database at Business Quant, Aquestive Therapeutics' Other Non-Current Assets surged by 262048.61% in 2021 and then plummeted by 2437.35% in 2025.
  • Aquestive Therapeutics' Other Non-Current Assets (Quarter) stood at $6.9 million in 2021, then dropped by 6.55% to $6.5 million in 2022, then dropped by 15.7% to $5.4 million in 2023, then dropped by 22.34% to $4.2 million in 2024, then dropped by 24.25% to $3.2 million in 2025.
  • Its Other Non-Current Assets stands at $3.2 million for Q3 2025, versus $3.2 million for Q2 2025 and $4.2 million for Q1 2025.